Study guide
1.2 Renal Anatomy, Physiology & Glomerular Hemodynamics
Board Certified Specialist in Renal Nutrition CSR
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Kidney Disease Foundations
1.1 CDR CSR Exam Structure, Eligibility, Logistics & the 2023 Content Outline 1.2 Renal Anatomy, Physiology & Glomerular Hemodynamics 1.3 CKD Etiology, KDIGO Staging & Progression Risk
2 Chapter 2: Domain 1 — Anthropometric & Body Composition Assessment
2.1 Dry Weight Determination, Fluid Assessment & Interdialytic Weight Gain 2.2 Anthropometric Measurement Standards (Knee Height, Skinfolds, Frame Size) 2.3 Body Composition Analysis: BIA, BIS, DXA & Handgrip Dynamometry
3 Chapter 3: Domain 1 — Nutrition-Focused Physical Findings & PEW Assessment Tools
3.1 Protein-Energy Wasting (PEW) Diagnostic Criteria & Pathophysiology 3.2 Subjective Global Assessment (7-Point SGA) in Dialysis 3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols 3.4 Nutrition-Focused Physical Exam (NFPE) for Muscle & Fat Loss
4 Chapter 4: Domain 1 — Diet, Medical, Medication & Psychosocial History
4.1 Dietary Intake Assessment & Food Frequency Methods in CKD 4.2 Medical & Medication History: Drug–Nutrient Interactions and Supplements 4.3 Psychosocial, Social & Functional History in Renal Nutrition Assessment
5 Chapter 5: Domain 1 — Medical Tests & Procedures by Treatment Modality
5.1 Hemodialysis Clinical Assessment & Vascular Access Considerations 5.2 Peritoneal Dialysis & Peritoneal Glucose Absorption Assessment 5.3 AKI, CRRT & Pediatric Renal Disease Assessment
6 Chapter 6: Domain 1 — Nutrition Diagnosis: Terminology, Etiology & Reasoning
6.1 Standardized Nutrition Diagnostic Terminology (NCP) in Nephrology 6.2 Etiology & Root-Cause Analysis for Renal Nutrition Problems 6.3 Diagnostic Reasoning for Fluid, Mineral & Protein Imbalances
7 Chapter 7: Domain 1 — Nutrition Diagnosis in Complex Patients
7.1 Formulating Valid PES Statements in Complex Dialysis Patients 7.2 Differentiating PEW, Sarcopenia & Cachexia in CKD 7.3 Diagnostic Prioritization across Cardiorenal & Diabetic Nephropathy
8 Chapter 8: Domain 2 — Food & Nutrient Delivery: Protein & Energy
8.1 KDOQI 2020 Protein Targets: Non-Dialysis CKD (LPD vs. VLPD) 8.2 Protein Prescriptions for Hemodialysis and Peritoneal Dialysis 8.3 Energy Requirements, Carbohydrates & Plant-Dominant Diets (PLADO)
9 Chapter 9: Domain 2 — Electrolytes, Fluid, Acid–Base & Micronutrients
9.1 Potassium Management: Dietary Restriction, Leaching & K-Binders 9.2 Sodium & Fluid Prescriptions across Dialysis Modalities 9.3 Acid-Base Homeostasis & Bicarbonate Replacement Therapy 9.4 Micronutrient, Trace Mineral & Vitamin Supplementation in ESRD
10 Chapter 10: Domain 2 — Medications & Specialized Nutrition Support
10.1 CKD-MBD Pharmacology: Phosphorus Binders, Vitamin D & Calcimimetics 10.2 Anemia Management: Iron Homeostasis, IV Iron Protocols & ESAs 10.3 Enteral, IDPN & Intraperitoneal Amino Acid Nutrition Support
11 Chapter 11: Domain 2 — Treatments Across the Continuum: Transplant & Comorbidities
11.1 Kidney Transplant I: Candidacy, Living Donors & the Early Post-Transplant Period 11.2 Kidney Transplant II: Long-Term Care, Immunosuppressant Side Effects & Graft Protection 11.3 Diabetes Management Across CKD Stages: Glycemic Targets, Medications & MNT 11.4 GI & Cardiovascular Comorbidities: Gastroparesis, Constipation, Liver Disease, Lipids & Blood Pressure
12 Chapter 12: Domain 2 — Monitoring & Evaluation: Labs, Fluid & Nutrition Trends
12.1 Renal Laboratory Surveillance: Frequency, Target Ranges & Trending 12.2 Monitoring Fluid Balance, Blood Pressure & Cardiovascular Risk 12.3 Longitudinal Assessment of Nutritional Status & Weight Trajectories
13 Chapter 13: Domain 2 — Monitoring Dialysis Adequacy & Kinetics
13.1 Hemodialysis Adequacy: Urea Kinetic Modeling, spKt/V & URR 13.2 Peritoneal Dialysis Adequacy & Peritoneal Equilibration Test (PET) 13.3 Normalized Protein Catabolic Rate (nPCR / nPNA) Interpretation 13.4 Troubleshooting Inadequate Dialysis vs. Dietary Non-Adherence
14 Chapter 14: Domain 2 — Care Coordination, Communication & Education
14.1 Interdisciplinary Team Care, Patient Education & Counseling Ethics 14.2 Individualized & Group Education: Medicare MNT and KDE Benefits, Caregivers & Curricula 14.3 Interfacility Coordination of Care: Hospital Handoffs, Transfers, Transplant Centers & Modality Changes 14.4 Psychosocial Support & Resources: Food Assistance, Financial Programs, Rehabilitation & Peer Support
15 Chapter 15: Domain 3 — Regulations & Quality Management
15.1 CMS Conditions for Coverage: IDT, Dietitian Qualifications, Assessment & Plan-of-Care Timelines 15.2 QAPI Programs, PDSA Cycles & the ESRD Quality Incentive Program 15.3 Medicare ESRD Payment, ESRD Networks, EQRS & the Survey Measures Assessment Tool
16 Chapter 16: Domain 3 — Evidence-Based Practice: Guidelines, Research & Protocols
16.1 The KDOQI 2020 Nutrition in CKD Guideline (NKF–Academy EAL): Grades & Key Statements 16.2 KDIGO & Companion Guidelines: CKD 2024, CKD-MBD, Anemia 2026, Diabetes, BP, Lipids & AKI 16.3 Appraising Current Research: Study Designs, Bias, Statistics & Landmark Renal Trials 16.4 Clinical Protocols & Algorithms: Dietitian-Managed MBD, Anemia, Potassium & Nutrition-Support Pathways
1.2 Renal Anatomy, Physiology & Glomerular Hemodynamics
Key Takeaways Explain This Topic AI
The kidneys receive 20% to 25% of resting cardiac output (~1.0–1.2 L/min of renal blood flow), filtering approximately 180 liters of plasma daily through roughly two million nephrons.
The three-layer glomerular filtration barrier prevents proteinuria through mechanical size exclusion (podocyte slit diaphragms of 4–11 nm) and electrostatic charge repulsion (negatively charged heparan sulfate proteoglycans in the GBM).
Autoregulation of GFR is governed by the myogenic mechanism and tubuloglomerular feedback (TGF) at the macula densa, which senses luminal NaCl delivery via NKCC2 cotransporters.
Intraglomerular capillary pressure is modulated by opposing vascular tones: Angiotensin II preferentially constricts the efferent arteriole to sustain GFR, whereas vasodilatory prostaglandins (PGE2, PGI2) dilate the afferent arteriole.
The simultaneous inhibition of renal prostaglandins by NSAIDs and angiotensin II by ACE inhibitors or ARBs precipitates acute hemodynamic GFR reduction and functional renal failure.
Last updated: September 2026
Renal Anatomy, Physiology & Glomerular Hemodynamics
A thorough understanding of renal anatomy and microscopic transport physiology is essential for evaluating laboratory alterations, fluid imbalances, and pharmacologic interactions in patients with kidney disease. The adult human kidneys are paired retroperitoneal organs positioned between the twelfth thoracic (T12) and third lumbar (L3) vertebrae. Despite accounting for less than 0.5% of total body weight, the kidneys receive 20% to 25% of resting cardiac output , representing a renal blood flow (RBF) of 1.0 to 1.2 liters per minute (~600–650 mL/min of renal plasma flow [RPF]). This extensive perfusion is required not to sustain renal metabolic demand, but to drive continuous high-volume plasma ultrafiltration.
Macroscopic Architecture & Renal Vasculature
Coronal sectioning of the kidney reveals two primary anatomic regions: an outer renal cortex and an inner renal medulla . Macroscopic Renal Architecture
- ┌─────────────────────────────────────────────────────────────────┐
- │ Renal Cortex (90% RBF, Isotonic, Glomeruli & Convoluted Tubules)│
- │ ┌───────────────────────────────────────────────────────────┐ │
- │ │ Renal Medulla (10% RBF, Hypertonic Interstitium, Hypoxic)│ │
- │ │ • 8–18 Renal Pyramids │ │
- │ │ • Loops of Henle & Medullary Collecting Ducts │ │
- │ │ • Renal Papillae discharge urine into Minor Calyces │ │
- │ └───────────────────────────────────────────────────────────┘ │
- │ Minor Calyces ➔ Major Calyces ➔ Renal Pelvis ➔ Ureter │
- └─────────────────────────────────────────────────────────────────┘
Renal Cortex : Receives approximately 90% of renal blood flow. Contains all glomeruli, proximal convoluted tubules, and distal convoluted tubules. Interstitial osmolality matches systemic plasma (~290 mOsm/kg).
Renal Medulla : Divided into 8 to 18 striated conical structures termed renal pyramids . The bases of the pyramids face the cortex, while their apices ( renal papillae ) project into the minor calyces . Minor calyces unite to form two to three major calyces , which converge into the funnel-shaped renal pelvis before draining into the ureter. The medulla receives only ~10% of renal blood flow via specialized hairpin loops called the vasa recta . This limited blood flow preserves the hypertonic medullary gradient (reaching up to 1,200 mOsm/kg at the papilla) required for urinary concentration, but renders medullary cells vulnerable to ischemic hypoxia.
The Renal Microvascular Cascade
The vascular pathway of the kidney possesses a unique portal-like architecture consisting of two capillary beds arranged in series:
Renal Artery ⟶ Interlobar Arteries ⟶ Arcuate Arteries ⟶ Cortical Radiate (Interlobular) Arteries ⟶ Afferent Arterioles \text{Renal Artery} \longrightarrow \text{Interlobar Arteries} \longrightarrow \text{Arcuate Arteries} \longrightarrow \text{Cortical Radiate (Interlobular) Arteries} \longrightarrow \text{Afferent Arterioles} Renal Artery ⟶ Interlobar Arteries ⟶ Arcuate Arteries ⟶ Cortical Radiate (Interlobular) Arteries ⟶ Afferent Arterioles
Afferent Arterioles ⟶ Glomerular Capillaries (High Pressure) ⟶ Efferent Arterioles ⟶ Peritubular Capillaries / Vasa Recta (Low Pressure) ⟶ Venous Return \text{Afferent Arterioles} \longrightarrow \mathbf{\text{Glomerular Capillaries (High Pressure)}} \longrightarrow \text{Efferent Arterioles} \longrightarrow \mathbf{\text{Peritubular Capillaries / Vasa Recta (Low Pressure)}} \longrightarrow \text{Venous Return} Afferent Arterioles ⟶ Glomerular Capillaries (High Pressure) ⟶ Efferent Arterioles ⟶ Peritubular Capillaries / Vasa Recta (Low Pressure) ⟶ Venous Return
The glomerular capillary bed operates under high hydrostatic pressure (~50 mmHg) optimized for fluid filtration into Bowman's capsule. The downstream peritubular capillary bed (surrounding cortical tubules) and vasa recta (accompanying medullary loops of Henle) operate under low hydrostatic pressure (~10–15 mmHg) and elevated oncotic pressure (~32–35 mmHg), facilitating solute and water reabsorption back into the systemic circulation.
The Nephron & The Glomerular Filtration Barrier
Each human kidney contains approximately 800,000 to 1,200,000 functional filtering units known as nephrons . Nephrons are categorized into two major classes:
Cortical Nephrons (~85%) : Glomeruli reside in the outer and mid-cortex. They feature short loops of Henle that penetrate only the outer medulla and are invested by peritubular capillaries. They primarily mediate bulk solute and water reabsorption.
Juxtamedullary Nephrons (~15%) : Glomeruli reside deep in the cortex adjacent to the corticomedullary junction. They feature long loops of Henle that plunge deep into the inner medullary papilla, accompanied by specialized vasa recta capillaries. Juxtamedullary nephrons generate and maintain the hyperosmolar medullary interstitial gradient essential for maximal urine concentration.
The Glomerular Filtration Barrier (GFB)
The glomerular filtration barrier separates blood within the capillary lumen from the urinary space of Bowman's capsule. It acts as an ultra-selective sieve governed by molecular size and electrostatic charge : Glomerular Filtration Barrier
- ═══════════════════════════════════════════════════════════════════════
- Blood Lumen: Fenestrated Endothelium (Pores: 70–100 nm, Glycocalyx)
- ───────────────────────────────────────────────────────────────────────
- Basement Membrane (GBM): Laminin, Type IV Collagen, Heparan Sulfate
- (Negatively charged polyanions repel circulating anionic proteins)
- ───────────────────────────────────────────────────────────────────────
- Urinary Space: Podocyte Foot Processes & Slit Diaphragm (Pores: 4–11 nm)
- (Nephrin, Podocin, Actinin-4 anchor filtration slits)
- ═══════════════════════════════════════════════════════════════════════
Fenestrated Capillary Endothelium : Perforated by transcellular fenestrae measuring 70 to 100 nm in diameter. Endothelial cells are coated with a thick luminal glycocalyx rich in negatively charged sialic acid and heparan sulfate proteoglycans. This layer blocks cellular blood elements (erythrocytes, leukocytes, platelets) while admitting dissolved solutes.
Glomerular Basement Membrane (GBM) : An acellular extracellular matrix (250–350 nm thick) synthesized jointly by endothelial cells and podocytes. Composed of a meshwork of type IV collagen (specifically α 3 , α 4 , α 5 \alpha3, \alpha4, \alpha5 α 3 , α 4 , α 5 chains), laminin-521, nidogen, and rich arrays of the negatively charged proteoglycans agrin and perlecan . This dense polyanionic matrix provides strong electrostatic repulsion against negatively charged plasma proteins.
Visceral Podocytes and Slit Diaphragms : Specialized terminally differentiated epithelial cells that envelop the exterior surface of the glomerular capillaries. Podocytes extend primary trabeculae that branch into interdigitating foot processes ( pedicels ). The spaces between adjacent pedicels form filtration slits spanned by an extracellular protein zipper called the slit diaphragm , exhibiting pore dimensions of 4 to 11 nm . The slit diaphragm is organized around transmembrane adhesion proteins, primarily nephrin and podocin , anchored intracellularly to the actin cytoskeleton via CD2AP and α \alpha α -actinin-4.
Size and Charge Selectivity: The Case of Human Serum Albumin
Filtration depends on molecular radius, shape, and net electrical charge:
Solutes with an effective molecular radius < 2.0 nm < 2.0\text{ nm} < 2.0 nm (water, urea, creatinine, electrolytes, glucose) filter freely (sieving coefficient = 1.0).
Solutes with an effective radius > 4.2 nm > 4.2\text{ nm} > 4.2 nm are completely excluded by size restriction.
Human serum albumin possesses an effective molecular radius of 3.6 nm and a molecular weight of 66.5 kDa. Because 3.6 nm is smaller than the podocyte slit pore (4–11 nm), albumin could theoretically pass across the barrier if mechanical size exclusion were the sole filtering mechanism. However, at physiologic plasma pH (7.40), albumin carries a strong net negative charge ( − 19 -19 − 19 ). The dense negative charges of the endothelial glycocalyx, GBM heparan sulfate, and podocyte podocalyxin exert powerful electrostatic repulsion , resulting in an albumin sieving coefficient of < 0.001 < 0.001 < 0.001 .
Disruption of this electrostatic charge barrier (as observed in minimal change disease) or architectural disruption of the slit diaphragm complex (as seen in focal segmental glomerulosclerosis and diabetic glomerulosclerosis) permits pathologically large quantities of albumin to escape into the urinary filtrate, producing heavy proteinuria.
Glomerular Hemodynamics & Autoregulation
Under normal conditions, total glomerular filtration rate (GFR) averages 120 to 125 mL/min (~180 L/day) in healthy adults. Despite wide fluctuations in systemic mean arterial pressure (MAP) between 80 and 180 mmHg during physical exertion, sleep, and postural shifts, renal blood flow and GFR remain relatively constant. This stability is maintained by intrinsic renal autoregulation , which operates independently of extrinsic renal nerve innervation via two cooperative mechanisms:
1. The Myogenic Mechanism
An intrinsic vascular smooth muscle response within the afferent arteriole. When systemic arterial pressure rises, increased transmural stretch stimulates stretch-activated non-selective cation channels, inducing membrane depolarization. Voltage-gated L-type calcium channels open, promoting intracellular Ca 2 + \text{Ca}^{2+} Ca 2 + influx and rapid vasoconstriction of the afferent arteriole within 1 to 3 seconds. Conversely, a fall in systemic perfusion pressure relieves wall tension, eliciting compensatory afferent vasodilation.
2. Tubuloglomerular Feedback (TGF)
A negative feedback loop operated by the juxtaglomerular apparatus (JGA) , which links tubular fluid composition to single-nephron GFR. The JGA comprises the macula densa (specialized tall epithelial cells within the thick ascending limb of the loop of Henle), extraglomerular mesangial cells, and granular renin-producing cells in the afferent arteriole. Tubuloglomerular Feedback (TGF) Pathway
- ┌─────────────────────────────────────────────────────────────────────┐
- │ Elevated Systemic BP ➔ Increased Glomerular Capillary Pressure (Pgc)│
- │ │ │
- │ ▼ │
- │ Elevated Single-Nephron GFR │
- │ │ │
- │ ▼ │
- │ Increased Solute Delivery to Thick Ascending Limb (Loop of Henle) │
- │ │ │
- │ ▼ │
- │ Enhanced NaCl Uptake via Macula Densa Apical NKCC2 Cotransporter │
- │ │ │
- │ ▼ │
- │ Cell Swelling ➔ Basolateral ATP Hydrolysis ➔ Adenosine Release │
- │ │ │
- │ ▼ │
- │ Binding to Adenosine A1 Receptors on Afferent Vascular Smooth Muscle│
- │ │ │
- │ ▼ │
- │ Intracellular Ca2+ Influx ➔ Afferent Arteriolar Vasoconstriction │
- │ │ │
- │ ▼ │
- │ Reduced Pgc ➔ Normalization of GFR & Suppression of Renin Release │
- └─────────────────────────────────────────────────────────────────────┘
When GFR rises, increased tubular fluid delivers more Na + \text{Na}^+ Na + and Cl − \text{Cl}^- Cl − to the macula densa. Apical NKCC2 cotransporters transport Na + \text{Na}^+ Na + , K + \text{K}^+ K + , and 2 Cl − 2\text{Cl}^- 2 Cl − into the cells, activating basolateral Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -ATPase. The resulting consumption of ATP leads to intracellular generation and extracellular release of adenosine . Adenosine binds to A 1 \text{A}_1 A 1 purinergic receptors on adjacent afferent arteriolar vascular smooth muscle cells, triggering Ca 2 + \text{Ca}^{2+} Ca 2 + mobilization and afferent arteriolar constriction. This lowers glomerular capillary pressure ( P g c P_{gc} P g c ) back to baseline while concurrently suppressing renin secretion.
Starling Forces & Vasoactive Glomerular Regulation
Glomerular ultrafiltration is physically governed by the balance of hydrostatic and oncotic pressures across the capillary wall, expressed by Starling's equation:
P u f = Δ P − Δ π = ( P g c − P b s ) − σ ( π g c − π b s ) P_{uf} = \Delta P - \Delta \pi = (P_{gc} - P_{bs}) - \sigma (\pi_{gc} - \pi_{bs}) P u f = Δ P − Δ π = ( P g c − P b s ) − σ ( π g c − π b s )
Where:
- P g c P_{gc} P g c = Glomerular capillary hydrostatic pressure (~50–55 mmHg, promotes filtration)
- P b s P_{bs} P b s = Bowman's space hydrostatic pressure (~10–15 mmHg, opposes filtration)
π g c \pi_{gc} π g c = Glomerular capillary oncotic pressure (~20 mmHg at afferent end, rising to ~32–35 mmHg at efferent end as fluid is extracted; opposes filtration)
- π b s \pi_{bs} π b s = Bowman's space oncotic pressure (~0 mmHg in health, as proteins are excluded)
- σ \sigma σ = Reflection coefficient for plasma protein (~1.0)
Net ultrafiltration pressure ( P u f P_{uf} P u f ) begins at roughly + 15 mmHg +15\text{ mmHg} + 15 mmHg at the afferent entrance of the capillary and declines toward zero at the efferent exit as protein concentration rises, establishing filtration equilibrium .
Vasoactive Hormones: Angiotensin II vs. Renal Prostaglandins
Glomerular hemodynamics are dynamically balanced by two opposing hormonal systems:
Angiotensin II (ATII) : Potent systemic vasoconstrictor generated in response to renal hypoperfusion or sympathetic activation. ATII binds to AT 1 \text{AT}_1 AT 1 receptors located on both arterioles, but exerts preferential vasoconstrictive tone on the efferent arteriole due to its smaller basal diameter and localized receptor density. Constriction of the efferent exit increases vascular resistance downstream of the glomerulus, raising P g c P_{gc} P g c and preserving GFR even when renal plasma flow declines.
Renal Prostaglandins ( PGE 2 \text{PGE}_2 PGE 2 , PGI 2 \text{PGI}_2 PGI 2 / Prostacyclin) : Synthesized locally within renal vascular endothelium by cyclooxygenase enzymes (COX-1 and COX-2) in response to ATII, endothelin, or sympathetic discharge. Prostaglandins act as local counter-regulatory vasodilators that selectively relax the afferent arteriole , buffering against excessive ischemic vasoconstriction and sustaining renal plasma flow. Vasoactive Modulation of Glomerular Pressure
- ═════════════════════════════════════════════════════════════════════════
- Afferent Arteriole Efferent Arteriole
- (Input Valve) (Output Valve)
- ───────────────────────────── ─────────────────────────
Vasodilated by: Vasoconstricted by:
- Prostaglandins (PGE2, PGI2) • Angiotensin II (AT1)
- Nitric Oxide (NO) • Endothelin
- Atrial Natriuretic Peptide
Vasodilated by:
- Vasoconstricted by: • ACE Inhibitors (blocks ATII)
- NSAIDs (blocks prostaglandins) • ARBs (blocks AT1 receptor)
- Adenosine (TGF mechanism)
- Endothelin, Norepinephrine
- ═════════════════════════════════════════════════════════════════════════
NET EFFECT ON GFR:
- Afferent Dilation + Efferent Constriction ➔ Elevated Pgc (Higher GFR)
- Afferent Constriction + Efferent Dilation ➔ Collapsing Pgc (Acute AKI)
- ═════════════════════════════════════════════════════════════════════════
- Clinical Pharmacology: The Nephrotoxic Synergy of NSAIDs and ACEi/ARBs
This hemodynamic balance explains the sharp decline in GFR observed when nonsteroidal anti-inflammatory drugs (NSAIDs) are administered to patients receiving angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs):
NSAIDs inhibit COX enzymes, abolishing protective prostaglandin synthesis and precipitating unbuffered afferent arteriolar vasoconstriction ("closing the inlet valve").
ACE inhibitors / ARBs eliminate ATII-mediated efferent arteriolar vasoconstriction ("opening the outlet valve").
The simultaneous constriction of the afferent inlet and dilation of the efferent outlet causes a collapse in glomerular capillary hydrostatic pressure ( P g c P_{gc} P g c ). Net ultrafiltration pressure falls below the threshold needed to maintain filtration, precipitating hemodynamic acute kidney injury (AKI) and marked hyperkalemia. In patients with preexisting CKD, renal artery stenosis, or intravascular volume depletion, this combination can precipitate acute anuric renal failure.
Segmental Tubular Physiology
After ultrafiltration, the primitive tubular filtrate undergoes sequential modification across specialized tubule segments:
Nephron Segment Solute & Fluid Reabsorption Profile Primary Transport Mechanisms & Endocrine Control
Proximal Convoluted Tubule (PCT) • 65–70% of filtered Na + \text{Na}^+ Na + , H 2 O \text{H}_2\text{O} H 2 O , Cl − \text{Cl}^- Cl − ; 80–90% of filtered HCO 3 − \text{HCO}_3^- HCO 3 − ; 100% of glucose and amino acids; 80–85% of filtered phosphate • NHE3 (apical Na + / H + \text{Na}^+/\text{H}^+ Na + / H + exchanger) drives H + \text{H}^+ H + secretion for HCO 3 − \text{HCO}_3^- HCO 3 − reclamation with carbonic anhydrase IV/II.; SGLT2 cotransports glucose with Na + \text{Na}^+ Na + .; NaPi-IIa / NaPi-IIc cotransporters reabsorb phosphate; down-regulated by PTH and FGF-23 to promote phosphaturia.
Loop of Henle (Thick Ascending Limb - TAL) • 20–25% of filtered Na + \text{Na}^+ Na + , K + \text{K}^+ K + , Cl − \text{Cl}^- Cl − ; Paracellular Ca 2 + \text{Ca}^{2+} Ca 2 + and Mg 2 + \text{Mg}^{2+} Mg 2 + ; Impermeable to water • NKCC2 apical cotransporter electroneutrally reabsorbs 1 Na + − 1 K + − 2 Cl − 1\text{Na}^+-1\text{K}^+-2\text{Cl}^- 1 Na + − 1 K + − 2 Cl − .; Apical K + \text{K}^+ K + recycling via ROMK generates a lumen-positive transepithelial voltage (+8 mV) that drives paracellular Ca 2 + \text{Ca}^{2+} Ca 2 + and Mg 2 + \text{Mg}^{2+} Mg 2 + absorption.; Target of loop diuretics (furosemide, bumetanide). Drives medullary hypertonicity.
Distal Convoluted Tubule (DCT) • 5–8% of filtered Na + \text{Na}^+ Na + and Cl − \text{Cl}^- Cl − ; Active transcellular Ca 2 + \text{Ca}^{2+} Ca 2 + reabsorption; Impermeable to water • NCC electroneutral Na + / Cl − \text{Na}^+/\text{Cl}^- Na + / Cl − cotransporter (inhibited by thiazide diuretics).; Apical TRPV5 calcium channel and basolateral NCX1 \text{NCX1} NCX1 reabsorb calcium under direct stimulation by PTH and calcitriol.
Collecting Duct (Cortical & Medullary) • 2–5% of filtered Na + \text{Na}^+ Na + ; Variable water reabsorption; Final regulation of K + \text{K}^+ K + , H + \text{H}^+ H + , HCO 3 − \text{HCO}_3^- HCO 3 − • Principal Cells : Apical ENaC channels reabsorb Na + \text{Na}^+ Na + ; ROMK secretes K + \text{K}^+ K + . Upregulated by aldosterone .; Basolateral V2 receptors respond to vasopressin (ADH) by shuttling Aquaporin-2 (AQP2) water channels into the apical membrane.; α \alpha α -Intercalated Cells : Apical H + \text{H}^+ H + -ATPase secretes acid; basolateral AE1 exports HCO 3 − \text{HCO}_3^- HCO 3 − .; β \beta β -Intercalated Cells : Apical pendrin (chloride-bicarbonate exchanger, Cl⁻/HCO₃⁻) secretes base during alkalosis.
Endocrine & Metabolic Functions of the Kidney
Beyond fluid and solute clearance, the kidneys function as vital endocrine organs regulating hematopoiesis, mineral metabolism, systemic blood pressure, and tissue aging:
Erythropoietin (EPO) Secretion : Glycoprotein hormone synthesized by peritubular interstitial fibroblasts residing in the deep renal cortex and outer medulla. In response to reduced renal tissue pO 2 \text{pO}_2 pO 2 , hypoxia-inducible factor 2 α 2\alpha 2 α (HIF-2 α \alpha α ) stabilizes, translocates to the nucleus, and activates the EPO gene. EPO circulates to the bone marrow to prevent apoptosis of erythroid progenitor cells (CFU-E). In progressive CKD, fibrotic transformation of interstitial fibroblasts impairs EPO synthesis, causing normochromic, normocytic anemia.
Activation of Vitamin D : The renal proximal tubular mitochondria express 25-hydroxyvitamin D 1 α 1\alpha 1 α -hydroxylase (CYP27B1) , the enzyme responsible for adding a hydroxyl group to 25-hydroxyvitamin D (calcidiol) to yield biologically active 1,25-dihydroxyvitamin D (calcitriol) . Renal 1 α 1\alpha 1 α -hydroxylase activity is stimulated by PTH and suppressed by hyperphosphatemia and Fibroblast Growth Factor 23 (FGF-23) . Loss of functional renal mass leads to calcitriol deficiency, secondary hyperparathyroidism, and metabolic bone disease.
Klotho Expression : Transmembrane protein produced predominantly in proximal and distal tubular epithelial cells. Soluble and membrane-bound Klotho functions as an obligate co-receptor for FGF-23, forming high-affinity FGF-23–FGFR1c complexes that induce phosphaturia and suppress 1 α 1\alpha 1 α -hydroxylase. Renal Klotho expression declines early in CKD, precipitating systemic FGF-23 resistance, hyperphosphatemia, and vascular calcification.
Renin Biosynthesis : Synthesized, stored, and secreted by granular juxtaglomerular cells in the afferent arteriole. Renin release is triggered by three stimuli: (a) decreased stretch of the afferent arteriole (hypotension), (b) reduced NaCl delivery sensed by the macula densa, and (c) direct sympathetic stimulation via renal β 1 \beta_1 β 1 -adrenergic receptors. Renin cleaves circulating angiotensinogen into angiotensin I, initiating the renin-angiotensin-aldosterone system (RAAS).